UA41915C2 - Засіб для інгібування проліферації і міграції клітин васкулярних гладенькіх м`язів у ссавців - Google Patents
Засіб для інгібування проліферації і міграції клітин васкулярних гладенькіх м`язів у ссавцівInfo
- Publication number
- UA41915C2 UA41915C2 UA95083997A UA95083997A UA41915C2 UA 41915 C2 UA41915 C2 UA 41915C2 UA 95083997 A UA95083997 A UA 95083997A UA 95083997 A UA95083997 A UA 95083997A UA 41915 C2 UA41915 C2 UA 41915C2
- Authority
- UA
- Ukraine
- Prior art keywords
- mammals
- migration
- agent
- vascular smooth
- inhibiting proliferation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Cardiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1993/002062 WO1994020096A1 (en) | 1993-03-05 | 1993-03-05 | Method of employing carbazolyl-(4)-oxypropanolamine compounds for inhibition of smooth muscle cell proliferation |
US08/026,892 US5308862A (en) | 1993-03-05 | 1993-03-05 | Use of, and method of treatment using, carbazolyl-(4)-oxypropanolamine compounds for inhibition of smooth muscle cell proliferation |
PCT/US1993/008019 WO1994020097A1 (en) | 1993-03-05 | 1993-08-27 | Use of, and method of treatment using, carbazolyl-(4)-oxypropanolamine compounds for inhibition of smooth muscle cell proliferation |
Publications (1)
Publication Number | Publication Date |
---|---|
UA41915C2 true UA41915C2 (uk) | 2001-10-15 |
Family
ID=26701782
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UA95083997A UA41915C2 (uk) | 1993-03-05 | 1993-08-27 | Засіб для інгібування проліферації і міграції клітин васкулярних гладенькіх м`язів у ссавців |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0746315A4 (no) |
JP (1) | JPH08508013A (no) |
AU (1) | AU679462B2 (no) |
NO (1) | NO307865B1 (no) |
RU (1) | RU2147433C1 (no) |
UA (1) | UA41915C2 (no) |
WO (2) | WO1994020096A1 (no) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6515009B1 (en) | 1991-09-27 | 2003-02-04 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2815926A1 (de) * | 1978-04-13 | 1979-10-18 | Boehringer Mannheim Gmbh | Neue carbazolyl-(4)-oxy-propanolamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
DE3319027A1 (de) * | 1983-05-26 | 1984-11-29 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verfahren zur herstellung von optisch aktiven carbazol-derivaten, neue r- und s-carbazol-derivate, sowie arzneimittel, die diese verbindungen enthalten |
US4970227A (en) * | 1984-11-20 | 1990-11-13 | Burroughs Wellcome Co. | Carbazole derivatives |
-
1993
- 1993-03-05 WO PCT/US1993/002062 patent/WO1994020096A1/en active Application Filing
- 1993-08-27 UA UA95083997A patent/UA41915C2/uk unknown
- 1993-08-27 JP JP6519937A patent/JPH08508013A/ja active Pending
- 1993-08-27 EP EP93920350A patent/EP0746315A4/en not_active Withdrawn
- 1993-08-27 WO PCT/US1993/008019 patent/WO1994020097A1/en not_active Application Discontinuation
- 1993-08-27 RU RU95121695A patent/RU2147433C1/ru not_active IP Right Cessation
- 1993-08-27 AU AU50923/93A patent/AU679462B2/en not_active Ceased
-
1995
- 1995-09-04 NO NO953480A patent/NO307865B1/no unknown
Also Published As
Publication number | Publication date |
---|---|
WO1994020096A1 (en) | 1994-09-15 |
EP0746315A4 (en) | 1999-01-07 |
RU2147433C1 (ru) | 2000-04-20 |
EP0746315A1 (en) | 1996-12-11 |
NO953480D0 (no) | 1995-09-04 |
AU679462B2 (en) | 1997-07-03 |
WO1994020097A1 (en) | 1994-09-15 |
AU5092393A (en) | 1994-09-26 |
NO307865B1 (no) | 2000-06-13 |
NO953480L (no) | 1995-11-03 |
JPH08508013A (ja) | 1996-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY116478A (en) | Tri-substituted imidazoles having multiple therapeutic properties | |
MX9707570A (es) | Utilizacion de agonistas de alta1l para el tratamiento de la incontinencia urinaria. | |
GEP20074251B (en) | N-oxycarbonyl substituted 5'- deoxy-5-fluorocytidines | |
MY114014A (en) | Imidazole compounds, compositions and use | |
MY106272A (en) | Use of 4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine derivatives in the treatment of psychosis, inflammation and as immunosuppressants. | |
HK1029922A1 (en) | Angiostatic agents and compositions for treating glc1a glaucoma | |
HU9502587D0 (en) | Use of, and method of treatment using, carbazolyl-(4)-oxypropanolamine compounds for inhibition of smooth muscle cell proliferation | |
PL316658A1 (en) | Novel application of serotonin antagonists | |
PL323825A1 (en) | Peptidyloheterocycli compounds useful in treating diorders associated with thrombosin | |
EP0717592A4 (en) | METHOD AND COMPOSITION FOR TREATING THE APATHIE DEMOTIVATION SYNDROME | |
GR3035725T3 (en) | Polyamine compounds for treating vascular proliferative disorders | |
MY111201A (en) | New imidazopyridines | |
EP0594410A3 (en) | Treatment of rubber articles. | |
EP0475434A3 (en) | Polymer composition and its use | |
PH31600A (en) | Methods of inhibiting atrophy of the skin and vagina. | |
EP0596962A4 (en) | Therapeutic compositions and methods. | |
WO1991018027A3 (en) | Compounds | |
ZA915371B (en) | Antitumor compositions and methods of treatment | |
EP0656069A4 (en) | CELL PROLIFERATION INHIBITORS, THEIR PRODUCTION AND USE. | |
AR244941A1 (es) | Compuesto, composicion, procedimiento y uso antimicrobiano. | |
AP9200355A0 (en) | "Therapeutic agent" | |
UA41915C2 (uk) | Засіб для інгібування проліферації і міграції клітин васкулярних гладенькіх м`язів у ссавців | |
HUT75529A (en) | Use of dimeticone for treating constipation | |
HUT57806A (en) | Copolymer composition comprising copolymer and one or more lubricants | |
GB9111439D0 (en) | Inhibition of vascular smooth muscle cell proliferation |